Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,038 | -88,613 | -207,299 | -107,205 | -22,191 |
| Depreciation Amortization | 3,179 | 7,610 | 9,404 | 10,566 | 10,094 |
| Accounts receivable | 2,449 | 2,428 | 7,769 | -4,812 | 6,444 |
| Other Working Capital | -12,380 | -12,372 | 17,691 | -11,078 | 3,296 |
| Other Operating Activity | 4,695 | 16,782 | 113,101 | 13,195 | -28,437 |
| Operating Cash Flow | $-53,095 | $-74,165 | $-59,334 | $-99,334 | $-30,794 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,815 | 45,146 | 22,492 | 122,866 | 17,142 |
| PPE Investments | 1,158 | -727 | -495 | -3,110 | -7,235 |
| Other Investing Activity | 84 | 1 | -1,161 | 525 | -525 |
| Investing Cash Flow | $12,057 | $44,420 | $20,836 | $120,281 | $9,382 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 108,745 | N/A | N/A |
| Debt Repayment | N/A | -1,486 | -52,155 | -5,763 | -6,722 |
| Common Stock Issued | 9,900 | 34 | 591 | 15,849 | 16,970 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 85 |
| Financing Cash Flow | $9,900 | $-1,452 | $57,181 | $10,086 | $10,333 |
| Beginning Cash Position | 68,467 | 99,664 | 80,981 | 49,948 | 61,027 |
| End Cash Position | 37,329 | 68,467 | 99,664 | 80,981 | 49,948 |
| Net Cash Flow | $-31,138 | $-31,197 | $18,683 | $31,033 | $-11,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,095 | -74,165 | -59,334 | -99,334 | -30,794 |
| Capital Expenditure | -35 | -1,322 | -624 | -3,110 | -7,235 |
| Free Cash Flow | -53,130 | -75,487 | -59,958 | -102,444 | -38,029 |